FDA approves first genetic test to assess opioid addiction risk using DNA sample

The U.S. Food and Drug Administration has approved AvertD, the first test designed to assess the risk of opioid use addiction in specific individuals, officials say. Read More in FOX News.   Read More in Red Pill NOWlej.